"Pfizer is deploying its financial resources to advance the fight against cancer," said Pfizer CEO Albert Bourla
PHOTO
US pharmaceutical giant Pfizer announced Monday it reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment, for $43 billion.
"Pfizer is deploying its financial resources to advance the fight against cancer," said Pfizer CEO Albert Bourla.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
